India · Delayed Price · Currency is INR Remus Pharmaceuticals Statistics
Total Valuation
NSE:REMUS has a market cap or net worth of INR 9.47 billion. The enterprise value is 9.70 billion.
| Market Cap | 9.47B |
| Enterprise Value | 9.70B |
Important Dates
The next estimated earnings date is Monday, November 10, 2025.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | Sep 18, 2025 |
Share Statistics
NSE:REMUS has 11.66 million shares outstanding. The number of shares has increased by 4.28% in one year.
| Current Share Class | 11.66M |
| Shares Outstanding | 11.66M |
| Shares Change (YoY) | +4.28% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 51.73% |
| Owned by Institutions (%) | n/a |
| Float | 5.52M |
Valuation Ratios
The trailing PE ratio is 32.94.
| PE Ratio | 32.94 |
| Forward PE | n/a |
| PS Ratio | 1.53 |
| PB Ratio | 3.35 |
| P/TBV Ratio | 3.84 |
| P/FCF Ratio | 315.74 |
| P/OCF Ratio | 135.70 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.23, with an EV/FCF ratio of 323.20.
| EV / Earnings | 33.35 |
| EV / Sales | 1.56 |
| EV / EBITDA | 21.23 |
| EV / EBIT | 22.13 |
| EV / FCF | 323.20 |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.82 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.50 |
| Debt / FCF | 7.66 |
| Interest Coverage | 30.01 |
Financial Efficiency
Return on equity (ROE) is 16.79% and return on invested capital (ROIC) is 11.07%.
| Return on Equity (ROE) | 16.79% |
| Return on Assets (ROA) | 7.15% |
| Return on Invested Capital (ROIC) | 11.07% |
| Return on Capital Employed (ROCE) | 14.09% |
| Revenue Per Employee | 91.23M |
| Profits Per Employee | 4.28M |
| Employee Count | 68 |
| Asset Turnover | 1.62 |
| Inventory Turnover | 11.26 |
Taxes
In the past 12 months, NSE:REMUS has paid 89.20 million in taxes.
| Income Tax | 89.20M |
| Effective Tax Rate | 18.84% |
Stock Price Statistics
The stock price has decreased by -20.52% in the last 52 weeks. The beta is 0.21, so NSE:REMUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -20.52% |
| 50-Day Moving Average | 794.60 |
| 200-Day Moving Average | 1,557.43 |
| Relative Strength Index (RSI) | 29.99 |
| Average Volume (20 Days) | 4,560 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:REMUS had revenue of INR 6.20 billion and earned 290.70 million in profits. Earnings per share was 24.67.
| Revenue | 6.20B |
| Gross Profit | 873.90M |
| Operating Income | 438.20M |
| Pretax Income | 473.40M |
| Net Income | 290.70M |
| EBITDA | 450.10M |
| EBIT | 438.20M |
| Earnings Per Share (EPS) | 24.67 |
Balance Sheet
The company has 272.70 million in cash and 229.80 million in debt, giving a net cash position of 42.90 million or 3.68 per share.
| Cash & Cash Equivalents | 272.70M |
| Total Debt | 229.80M |
| Net Cash | 42.90M |
| Net Cash Per Share | 3.68 |
| Equity (Book Value) | 2.83B |
| Book Value Per Share | 219.47 |
| Working Capital | 998.40M |
Cash Flow
In the last 12 months, operating cash flow was 69.80 million and capital expenditures -39.80 million, giving a free cash flow of 30.00 million.
| Operating Cash Flow | 69.80M |
| Capital Expenditures | -39.80M |
| Free Cash Flow | 30.00M |
| FCF Per Share | 2.57 |
Margins
Gross margin is 14.09%, with operating and profit margins of 7.06% and 4.69%.
| Gross Margin | 14.09% |
| Operating Margin | 7.06% |
| Pretax Margin | 7.63% |
| Profit Margin | 4.69% |
| EBITDA Margin | 7.26% |
| EBIT Margin | 7.06% |
| FCF Margin | 0.48% |
Dividends & Yields
This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 0.09%.
| Dividend Per Share | 0.75 |
| Dividend Yield | 0.09% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 4.06% |
| Buyback Yield | -4.28% |
| Shareholder Yield | -4.18% |
| Earnings Yield | 3.07% |
| FCF Yield | 0.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 4, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Jul 4, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
NSE:REMUS has an Altman Z-Score of 7.41 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.41 |
| Piotroski F-Score | 5 |